ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 687006 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 687006; 2) Community: the network communities that were significantly associated with the response to NSC 687006; 3) Molecule: the relationships between components within communities and NSC 687006; 4) MDR: the compounds that were significantly associated with the NSC 687006.

NSC Compound Enrichment Correlation
NSC 718630 Null 0.0392716453377535 0.23848978
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 -0.41308659
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.44941682
NSC 734288 6-(3-Azidopropyl)-5,6-dihydro-7,8-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline 0.0392716453377535 0.21750135
NSC 743532 Null 0.0392716453377535 -0.08129755
NSC 748902 [(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] 0.0392716453377535 0.34105041
NSC 751042 Null 0.0392716453377535 0.23637831
NSC 751605 (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide 0.0392716453377535 0.51051738
NSC 752761 Null 0.0392716453377535 -0.028722258
NSC 753377 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.0392716453377535 0.28961799
Total:74  Current:63    [First] [Prev] [Next] [Last]